Preliminary safety results of a phase II study investigating pembrolizumab in combination with postoperative intensity modulated radiotherapy (IMRT) in resected high risk cutaneous squamous cell cancer of the head and neck.
Year: 2019
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Shlomo A. Koyfman, Brian Gastman, Allison T. Vidimos, Nikhil Purushottam Joshi, Jennifer Lucas, Christine Poblete-Lopez, Alok Vij, Jon Meine, Brian B. Burkey, Jamie Ku, Eric Lamarre, Brandon Prendes, Joseph Scharpf, Steven D Billings, Julia Samsa, Shelley Beth Robinson, David J. Adelstein, Jessica Lyn Geiger
Institutions: Cleveland Clinic, All India Institute of Medical Sciences
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2947095610